Skip to main content
Jon Cuthbert Profile pIcture
Jon Cuthbert

Jon Cuthbert

GrafaFounder & COO

Jon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.

Articles by Jon Cuthbert

Grafa
Health

Greenwich LifeSciences reports 83% reduction in breast cancer recurrence in Phase III trial

Greenwich LifeSciences (NASDAQ:GLSI) released a preliminary update from its ongoing Phase III FLAMINGO-01 clinical trial, which evaluates the efficacy of GP2, an immunotherapy designed to prevent breast cancer recurrences.

Read more: Greenwich LifeSciences reports 83% reduction in breast cancer recurrence in Phase III trial